Synopsys Down over 9%, on Track for Lowest Close Since May 2023

Dow Jones
Jul 18

Synopsys, Inc. $(SNPS)$ is currently at $376.78, down $40.25 or 9.65%

 

--Would be lowest close since May 16, 2023, when it closed at $375.14

--On pace for largest percent decrease since Sept. 10, 2025, when it fell 35.84%

--Currently down five consecutive days; down 15.43% over this period

--Longest losing streak since Feb. 5, 2026, when it fell for six straight trading days

--Worst five day stretch since the five days ending Feb. 4, 2026, when it fell 18.06%

--Down 15.43% this week; worst weekly performance since the week ending Sept. 12, 2025, when it fell 28.87%

--Down 15.53% month-to-date

--Down 19.79% year-to-date

--Down 41.62% from its all-time closing high of $645.35 on July 30, 2025

--Down 35.57% from 52 weeks ago (July 18, 2025), when it closed at $584.76

--Down 41.62% from its 52-week closing high of $645.35 on July 30, 2025

--Would be a new 52-week closing low

--Traded as low as $366.00; lowest intraday level since April 7, 2025, when it hit $365.74

--Down 12.24% at today's intraday low; largest intraday percent decrease since Sept. 10, 2025, when it fell as much as 36.99%

--Third worst performer in the S&P 500 today

--Third worst performer in the Nasdaq 100 today

 

All data as of 3:30:22 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

July 17, 2026 15:33 ET (19:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10